Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [2866]

WCLC 2026: Study shows first-line amivantamab plus chemotherapy achieves longest overall survival reported in advanced NSCLC with EGFR exon 20 insertions

WCLC 2026: Study shows first-line amivantamab plus chemotherapy achieves longest overall survival reported in...

WCLC 2026: Eight-year ADAURA update shows sustained overall survival benefit with adjuvant osimertinib in resected EGFR-mutated NSCLC

WCLC 2026: Eight-year ADAURA update shows sustained overall survival benefit with adjuvant osimertinib in resected...

New MRI agent detects lung cancer, hidden metastases earlier than current scans

New MRI agent detects lung cancer, hidden metastases earlier than current scans

Patients diagnosed with lung cancer found to have more microplastic in their lungs

Patients diagnosed with lung cancer found to have more microplastic in their lungs

Adjuvant immunotherapy shows no survival benefit for NSCLC patients achieving pCR after neoadjuvant treatment

Adjuvant immunotherapy shows no survival benefit for NSCLC patients achieving pCR after neoadjuvant treatment

Lung tumour microenvironment established by simultaneous activation of KrasG12D and deletion of neddylation conjugation enzyme UBE2M

Lung tumour microenvironment established by simultaneous activation of KrasG12D and deletion of neddylation...

Daraxonrasib demonstrates initial antitumour activity in RAS-mutant lung cancer

Daraxonrasib demonstrates initial antitumour activity in RAS-mutant lung cancer

Cancer cachexia: How a tumour protein drives wasting in the body

Cancer cachexia: How a tumour protein drives wasting in the body

When the question is 'How long do I have?', survival still matters in ES-SCLC

When the question is 'How long do I have?', survival still matters in ES-SCLC

Scientists uncover hidden cell type that shields lung cancer

Scientists uncover hidden cell type that shields lung cancer

More from ecancer